The government's Innovation and Technology Commission has put together a team headed by Sir Colin Dollery, senior consultant to SmithKline Beecham, to study Hong Kong's resources and make recommendations on how it can best take advantage of the genetic revolution.
It's late to the game. Over the past six years, the government has invested just $100 million in biotechnology-related projects. Those funds have yielded almost nothing in the way of infrastructure or...
To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.
To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222
Hello! You have used up all of your free articles on FinanceAsia.
To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222
